Literature DB >> 2923005

Acute changes in cerebral blood flow associated with marijuana smoking.

R J Mathew1, W H Wilson, S R Tant.   

Abstract

Cerebral blood flow (CBF) was measured in experienced (ES) and inexperienced (IS) marijuana smokers with the 133xenon inhalation technique before and after smoking both a high-potency marijuana cigarette and a placebo marijuana cigarette. CBF was measured twice under resting conditions in a control group. Mood states before and after marijuana smoking were quantified with the Profile of Mood States (POMS). Analyses of POMS factors after smoking marijuana revealed IS had an increase in anxiety while ES had a decrease. IS also had a significant increase in depression and decrease in vigor, but neither variable changed in the ES. After marijuana, CBF decreased in IS, but in ES, it increased in comparison with the 2 control runs. In both IS and ES, CBF changes following placebo administration were similar to those associated with marijuana smoking. However, in IS, the marijuana-induced CBF decrease was significantly higher than that associated with placebo. There were no statistically significant differences between the CBF increase seen after placebo and marijuana in ES. Anxiety, anger, fatigue, confusion and depression had significant negative correlations with CBF while vigor correlated positively, but the anxiety factor was the only one to account for a significant percentage of the change (parital correlation) in hemispheric CBF.

Entities:  

Mesh:

Year:  1989        PMID: 2923005     DOI: 10.1111/j.1600-0447.1989.tb08579.x

Source DB:  PubMed          Journal:  Acta Psychiatr Scand        ISSN: 0001-690X            Impact factor:   6.392


  14 in total

1.  Spatial working memory in heavy cannabis users: a functional magnetic resonance imaging study.

Authors:  Gen Kanayama; Jadwiga Rogowska; Harrison G Pope; Staci A Gruber; Deborah A Yurgelun-Todd
Journal:  Psychopharmacology (Berl)       Date:  2004-06-16       Impact factor: 4.530

Review 2.  The endocannabinoid system as a target for modelling psychosis.

Authors:  Dagmar Koethe; Carolin Hoyer; F Markus Leweke
Journal:  Psychopharmacology (Berl)       Date:  2009-06-16       Impact factor: 4.530

3.  THC and endocannabinoids differentially regulate neuronal activity in the prefrontal cortex and hippocampus in the subchronic PCP model of schizophrenia.

Authors:  David D Aguilar; Andrea Giuffrida; Daniel J Lodge
Journal:  J Psychopharmacol       Date:  2015-10-28       Impact factor: 4.153

4.  Emotion Expression and Substance Use in Newly Parenting Adolescents and Young Adults.

Authors:  Alethea Desrosiers; Heather Sipsma; Anna Divney; Urania Magriples; Trace Kershaw
Journal:  J Clin Psychol       Date:  2015-03-26

5.  Altered cerebral blood flow and neurocognitive correlates in adolescent cannabis users.

Authors:  Joanna Jacobus; Diane Goldenberg; Christina E Wierenga; Neil J Tolentino; Thomas T Liu; Susan F Tapert
Journal:  Psychopharmacology (Berl)       Date:  2012-03-07       Impact factor: 4.530

6.  Effects of cannabis on cognition in patients with MS: a psychometric and MRI study.

Authors:  Bennis Pavisian; Bradley J MacIntosh; Greg Szilagyi; Richard W Staines; Paul O'Connor; Anthony Feinstein
Journal:  Neurology       Date:  2014-04-30       Impact factor: 9.910

7.  Cerebral blood flow and metabolism in anxiety and anxiety disorders.

Authors:  R J Mathew
Journal:  Indian J Psychiatry       Date:  1994-07       Impact factor: 1.759

Review 8.  Biomarkers for the effects of cannabis and THC in healthy volunteers.

Authors:  Lineke Zuurman; Annelies E Ippel; Eduard Moin; Joop M A van Gerven
Journal:  Br J Clin Pharmacol       Date:  2009-01       Impact factor: 4.335

Review 9.  Acute and non-acute effects of cannabis on brain functioning and neuropsychological performance.

Authors:  Raul Gonzalez
Journal:  Neuropsychol Rev       Date:  2007-09       Impact factor: 7.444

10.  Rapid increase in the prevalence of cannabis use among people with depression in the United States, 2005-17: the role of differentially changing risk perceptions.

Authors:  Lauren R Pacek; Andrea H Weinberger; Jiaqi Zhu; Renee D Goodwin
Journal:  Addiction       Date:  2019-12-20       Impact factor: 6.526

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.